---
title: "Xizang Weixinkang Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 219 million yuan, a year-on-year decrease of 9.9%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263318444.md"
description: "According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical disclosed its third-quarter report for 2025. The company achieved revenue of 862 million yuan in the first three quarters, a year-on-year decrease of 13.27%; net profit attributable to the parent company was 219 million yuan, a year-on-year decrease of 9.9%; net profit excluding non-recurring gains and losses was 169 million yuan, a year-on-year decrease of 14.01%; basic earnings per share were 0.51 yuan"
datetime: "2025-10-29T14:22:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263318444.md)
  - [en](https://longbridge.com/en/news/263318444.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263318444.md)
generator: "portal-rs"
---

# Xizang Weixinkang Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 219 million yuan, a year-on-year decrease of 9.9%

According to the Zhitong Finance APP, Xizang Weixinkang Pharmaceutical (603676.SH) disclosed its third-quarter report for 2025. The company achieved revenue of 862 million yuan in the first three quarters, a year-on-year decrease of 13.27%; net profit attributable to shareholders was 219 million yuan, a year-on-year decrease of 9.9%; net profit excluding non-recurring gains and losses was 169 million yuan, a year-on-year decrease of 14.01%; basic earnings per share were 0.51 yuan

### Related Stocks

- [603676.CN](https://longbridge.com/en/quote/603676.CN.md)

## Related News & Research

- [This Atlassian Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday](https://longbridge.com/en/news/297053341.md)
- [MedicalRite Announces COVID-19 & Flu Combo Test for Better Health](https://longbridge.com/en/news/297204162.md)
- [03:39 ETWalovi Accelerates Global Push with WALOVI Singapore HQ Launch and Trio of Southeast Asia Deals](https://longbridge.com/en/news/297003145.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [Citi Downgrades COSCO SHIP HOLD , Evergreen Marine and Yang Ming to Neutral, Adjusts TPs](https://longbridge.com/en/news/296859156.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**